Emily M Coonrod
Overview
Explore the profile of Emily M Coonrod including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
354
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liao M, Webster J, Coonrod E, Weilbaecher K, Maher C, White N
Clin Breast Cancer
. 2024 Mar;
24(4):368-375.e2.
PMID: 38443227
Background: Breast cancer, particularly the estrogen receptor positive (ER+) subtype, remains a leading cause of cancer-related death among women. Endocrine therapy is the most effective treatment for ER+ breast cancer;...
2.
Huber A, Pineda D, Liu D, Boschert K, Gres A, Wolf J, et al.
ACS Infect Dis
. 2018 Dec;
5(5):750-758.
PMID: 30582687
An estimated 240 million are chronically infected with hepatitis B virus (HBV), which can lead to liver disease, cirrhosis, and hepatocellular carcinoma. Currently, HBV treatment options include only nucleoside reverse...
3.
Huber A, Wolf J, Liu D, Gres A, Tang J, Boschert K, et al.
mSphere
. 2018 Apr;
3(2).
PMID: 29669885
Heteroaryldihydropyrimidines (HAPs) are compounds that inhibit hepatitis B virus (HBV) replication by modulating viral capsid assembly. While their biophysical effects on capsid assembly have been previously studied, the effect of...
4.
Kumanovics A, Lee Y, Close D, Coonrod E, Ujhazi B, Chen K, et al.
J Allergy Clin Immunol
. 2016 Sep;
139(2):690-692.e3.
PMID: 27609655
No abstract available.
5.
Buchbinder D, Baker R, Lee Y, Ravell J, Zhang Y, McElwee J, et al.
J Clin Immunol
. 2014 Dec;
35(2):119-24.
PMID: 25516070
Purpose: Combined immunodeficiency (CID) presents a unique challenge to clinicians. Two patients presented with the prior clinical diagnosis of common variable immunodeficiency (CVID) disorder marked by an early age of...
6.
Coonrod E, Durtschi J, VanSant Webb C, Voelkerding K, Kumanovics A
Biotechniques
. 2014 Oct;
57(4):204-7.
PMID: 25312090
Next-generation sequencing (NGS) of multigene panels performed for genetic clinical diagnostics requires 100% coverage of all targeted genes. In the genetic diagnostics laboratory, coverage gaps are typically filled with Sanger...
7.
Coonrod E, Graham L, Carpp L, Carr T, Stirrat L, Bowers K, et al.
Dev Cell
. 2013 Nov;
27(4):462-8.
PMID: 24286827
Studies of homotypic vacuole-vacuole fusion in the yeast Saccharomyces cerevisiae have been instrumental in determining the cellular machinery required for eukaryotic membrane fusion and have implicated the vacuolar H(+)-ATPase (V-ATPase)....
8.
Durtschi J, Margraf R, Coonrod E, Mallempati K, Voelkerding K
BMC Bioinformatics
. 2013 Nov;
14 Suppl 13:S2.
PMID: 24266885
Background: Variant discovery for rare genetic diseases using Illumina genome or exome sequencing involves screening of up to millions of variants to find only the one or few causative variant(s)....
9.
Chen K, Coonrod E, Kumanovics A, Franks Z, Durtschi J, Margraf R, et al.
Am J Hum Genet
. 2013 Oct;
93(5):812-24.
PMID: 24140114
Common variable immunodeficiency (CVID) is a heterogeneous disorder characterized by antibody deficiency, poor humoral response to antigens, and recurrent infections. To investigate the molecular cause of CVID, we carried out...
10.
Coonrod E, Margraf R, Russell A, Voelkerding K, Reese M
Expert Rev Mol Diagn
. 2013 Jul;
13(6):529-40.
PMID: 23895124
Aims: Next-generation sequencing is being implemented in the clinical laboratory environment for the purposes of candidate causal variant discovery in patients affected with a variety of genetic disorders. The successful...